Canafarma Hemp Products (CSE: CNFA) this morning announced that it is working towards bringing its newest hemp-oil infused product line to market, with the first product being that of an acne skin care topical., designed to combat conditions specific to acne.
The latest product is being designed in conjunction with Carl Germano, an authority in the cannabinoid and nutritional industry. Together, the group is currently developing a ream that is designed to provide releaf support to sufferers of acne vulgaris, a skin disease that affects 79% to 95% of the adolescent population.
The skin cream is to be launched by the the end of the second quarter, and is formulated to utilize the full cannabinoid spectrum found in hemp oil. Specifically, the cream will target three specific characteristics of acne: oil production, inflammation, and bacteria.
Based on a 2014 study conducted and subsequently published in the Journal of Clinical Investigation, it was found that cannabinoids prevent cells from creating too much sebum, the substance that clogs pores and results in acne. Meanwhile, cannabinoids were also found to contribute anti-inflammatory properties, while a subsequent study has found certain antibacterial and antifungal effects.
The product is expected to be launched by the end of the second quarter of 2020, with the exact date to be announced in due course.
Canafarma Hemp Products last traded at $0.80 on the CSE.
FULL DISCLOSURE: Canafarma Hemp Products Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Canafarma Hemp Products Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
